>I think it significantly raises the prospects for a buyout of ONXX.<
Not sure why everyone is all buyout crazy lately. I commented on the aria buyout purely on a hypothetical basis, but I don't want a buyout. As for Onyx, it seems like an even worse proposition. If they're able to get a second drug on the market, then I think they reach that sweet spot of really making some money.
I don't know why management would accept a buyout, or why investors would speculate on it as if it is an exciting prospect.
Market Data 
Markets 
AI
